• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sirtex Medical Ltd

+ Add to Watchlist

SXMDF:US

21.2100 USD 0.9600 4.74%

As of 10:15:35 ET on 09/02/2014.

Snapshot for Sirtex Medical Ltd (SXMDF)

Open: 21.2300 Day's Range: 21.2100 - 21.2300 Volume: 340
Previous Close: 20.2500 52wk Range: 9.8000 - 21.2300 1-Yr Rtn: -

Stock Chart for SXMDF

No chart data available.
  • SXMDF:US 21.2100
  • 1D
  • 1M
  • 1Y
20.2500
Interactive SXMDF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SXMDF

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 41.5780
Relative P/E vs. SPX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) 0.5500
Est. PEG Ratio 1.4142
Market Cap (M USD) 1,198.25
Shares Outstanding (M) 56.49
30 Day Average Volume 1,304
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.76%
Cash Dividend (AUD) 0.1200
Dividend Ex-Date 10/04/2013
5 Year Dividend Growth -
Next Earnings Announcement 02/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SXMDF

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for SXMDF

Sirtex Medical Limited is a medical company which researches, develops and commercializes medical products for the treatment of liver cancer. The Company is based in Western Australia and markets its products throughout the world. The Company's products include "SIR-Spheres," which uses micro-particle technology to treat liver cancer.

Gilman WongCEO/Exec Dir/Mng DirDarren SmithCFO/Secretary
David CadeChief Medical OfficerNigel LangeCEO:Europe
More Company Profile & Key Executives for SXMDF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil